Deriv executivedirector of the Cyprus office, Geo Nicolaidis, is leaving the company aftermore than four years with the retail FX and CFDs broker.Nicolaidis recentlylaunched TrailBit.io, a Bitcoin blockchain analytics venture focused onforensic and research tools for individuals and organizations. The company publishes research findings through TrailBit Labs whileoffering analytics tools through its platform.Deriv Executive Builds AI AutomationSystemsDuring his time atDeriv, Nicolaidis held several senior positions, including Executive Directorof the Cyprus office, Senior Product Manager, and most recently TechnicalProduct Owner for AI Automations.In the executive role,he oversaw the expansion of the Cyprus operation and helped establish hiringprocesses and operational infrastructure. He said the office earned Great Placeto Work certification for three consecutive years as well as Investors in PeoplePlatinum accreditation during his tenure.Alongside hismanagement responsibilities, Nicolaidis worked on projects tied to tradingplatforms, affiliate systems, and developer APIs. In his latest role, hefocused on AI automation tools across multiple departments. According to his LinkedIn profile, the work involved workflow automation, prompt engineering, APIintegration, and internal operational tools.XAmplifier Role Focuses on US SaaS BuildBefore joining Deriv,Nicolaidis spent nearly a year at FXGT as Senior Product Manager, where heworked on the redesign of client and partner trading platforms.Earlier, he was partof the founding team at XAmplifier, serving as Managing Director for Europe fornearly a decade. According to his profile, he helped build a SaaS platform usedby 2.5 million patients in the United States and established the company’sEuropean headquarters.Deriv Moves to Single CEO StructureLast year, Derivmoved to a single Chief Executive Officer structure following changes inits top leadership, with co-founder Jean-Yves Sireau stepping back fromexecutive management. The company appointed Rakshit Choudhary as sole CEO,ending the previous co-CEO arrangement. Sireau, who spent nearly 25 years at thefirm, stepped away from day-to-day responsibilities but remains the majorityshareholder and is expected to continue in a strategic capacity. He has alsolaunched a new venture focused on AI-driven health optimisation.This article was written by Tareq Sikder at www.financemagnates.com.